We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 11,724

Revised FDA Ingredient Listing Guidance for Tobacco Products Published, Exempts Non-Consumable Product Hardware and Components and Parts From Section 904(a)(1) Listing Requirement
  • Keller and Heckman LLP
  • USA
  • April 16 2018

The vapor device industry has been requesting FDA for years to exempt devices from the Tobacco Control Act Section 904(a)(1) ingredient listing


Washington Healthcare Update - Apr 16, 2018
  • McGuireWoods LLP
  • USA
  • April 16 2018

On April 11, Speaker of the House Paul Ryan announced he would not run for re-election to Congress. Already some in the House are suggesting Ryan


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • April 16 2018

Lawmakers return today to Capitol Hill after a two-week recess, and multiple committees in both the House and Senate are poised


A U.S. Perspective on Global Strategy
  • Sterne Kessler Goldstein & Fox PLLC
  • USA, Taiwan
  • April 13 2018

In December 2017, the Taiwan Pharmaceutical Affairs Act has been amended to harmonize generic approval process with prevailing international norms


Report Details Uneven Implementation of the New Drug Tracing Law
  • Mintz Levin
  • USA
  • April 13 2018

Last month, the Department of Health and Human Services’ Office of Inspector General (OIG) released its latest report on compliance with the Drug


New Data Requirements for Non-U.S. Clinical Investigations
  • Dykema Gossett PLLC
  • USA
  • April 12 2018

The U.S. Food and Drug Administration (FDA) recently issued a final rule describing the criteria for using clinical research data from clinical


States Regulating PFAS in Food Packaging: What You Need to Know Now
  • Pepper Hamilton LLP
  • USA
  • April 12 2018

Last month, Washington state enacted a new law, making it the first in the country to ban the use of perfluoroalkyl and polyfluoroalkyl substances, or


Developments in FDA & DOJ Regulation and Enforcement of Manufacturer Communications
  • Ropes & Gray LLP
  • USA
  • April 12 2018

The rules regarding truthful, non-misleading communications by medical product manufacturers have long been unclear. In recent years, there have been


Menu labeling rules go into effect in May 2018
  • Greensfelder Hemker & Gale PC
  • USA
  • April 12 2018

After repeated delays, the compliance deadline for the Food and Drug Administration’s (FDA) new federal menu labeling rules requiring disclosure of


FDA Approval for Auris’ Robotic Endoscopy Platform
  • Knobbe Martens
  • USA
  • April 11 2018

On March 23, Auris Health, Inc. announced FDA clearance for the Monarch Platform, Auris’ new system for robotic endoscopy. According to Auris Health